In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

Known for its traditional health benefits, this remarkable fungus may hold the key to slowing cancer progression, according ...

In 1937, President Franklin Roosevelt signed the National Cancer Act, launching a nationwide effort to combat the disease.

Due to the frequent mutations that enable drug resistance, lung cancer remains particularly ... It is a proof of concept that ...

Scientists have developed a groundbreaking cancer treatment that works like a precision-guided missile with a powerful immune ...

Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...

Researchers at the University of Virginia have discovered a new mechanism driving drug resistance in pancreatic ductal ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025.

Researchers reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected 'second jobs' within the nucleus, orchestrating critical ...